Miguel Ángel
González-Gay Mantecón
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublications in collaboration with researchers from Hospital Universitari de Bellvitge (8)
2023
-
Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients
Seminars in Arthritis and Rheumatism, Vol. 58
-
Mucosal Immune Defence Gene Polymorphisms as Relevant Players in the Pathogenesis of IgA Vasculitis?
International Journal of Molecular Sciences, Vol. 24, Núm. 17
-
Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients
Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 829-836
2022
-
IgA Vasculitis: Influence of CD40, BLK and BANK1 Gene Polymorphisms
Journal of Clinical Medicine, Vol. 11, Núm. 19
-
Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients
Therapeutic Advances in Musculoskeletal Disease, Vol. 14
2021
-
HLA association with the susceptibility to anti-synthetase syndrome
Joint Bone Spine, Vol. 88, Núm. 3
-
Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review
Therapeutic Advances in Musculoskeletal Disease, Vol. 13
2019
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089